Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons
- PMID: 15194435
- DOI: 10.1016/j.yexcr.2004.02.028
Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons
Abstract
The aim of this study was to evaluate whether the direct activation of the Wnt signaling pathway by its endogenous Wnt-3a ligand prevents the toxic effects induced by amyloid-beta-peptide (Abeta) in rat hippocampal neurons. We report herein that the Wnt-3a ligand was indeed able to overcome toxic effects induced by Abeta in hippocampal neurons, including a neuronal impairment on cell survival, an increase in glycogen synthase kinase-3beta (GSK-3beta) and tau phosphorylation, a decrease in cytoplasmic beta-catenin and a decrease in the expression of the Wnt target gene engrailed-1. We further demonstrate that Wnt-3a protects hippocampal neurons from apoptosis induced by Abeta. Our results support the hypothesis that a loss of function of Wnt signaling may play a role in the progression of neurodegenerative diseases such as Alzheimer's disease.
Similar articles
-
The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.Neurobiol Dis. 2005 Feb;18(1):176-83. doi: 10.1016/j.nbd.2004.09.012. Neurobiol Dis. 2005. PMID: 15649708
-
Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.Mol Psychiatry. 2003 Feb;8(2):195-208. doi: 10.1038/sj.mp.4001208. Mol Psychiatry. 2003. PMID: 12610652
-
Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway.FASEB J. 2002 Dec;16(14):1982-4. doi: 10.1096/fj.02-0327fje. Epub 2002 Oct 18. FASEB J. 2002. PMID: 12397090
-
Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.Brain Res Brain Res Rev. 2004 Dec;47(1-3):275-89. doi: 10.1016/j.brainresrev.2004.07.018. Brain Res Brain Res Rev. 2004. PMID: 15572177 Review.
-
Synaptotoxicity in Alzheimer's disease: the Wnt signaling pathway as a molecular target.IUBMB Life. 2007 Apr-May;59(4-5):316-21. doi: 10.1080/15216540701242490. IUBMB Life. 2007. PMID: 17505971 Review.
Cited by
-
Peroxisome Proliferator-activated Receptor (PPAR)-γ Modifies Aβ Neurotoxin-induced Electrophysiological Alterations in Rat Primary Cultured Hippocampal Neurons.Iran J Pharm Res. 2019 Summer;18(3):1403-1418. doi: 10.22037/ijpr.2019.1100783. Iran J Pharm Res. 2019. PMID: 32641950 Free PMC article.
-
WNT5A, β‑catenin and SUFU expression patterns, and the significance of microRNA deregulation in placentas with intrauterine growth restriction.Mol Med Rep. 2023 Feb;27(2):28. doi: 10.3892/mmr.2022.12914. Epub 2022 Dec 16. Mol Med Rep. 2023. PMID: 36524356 Free PMC article.
-
Hypermethylation of Mest promoter causes aberrant Wnt signaling in patients with Alzheimer's disease.Sci Rep. 2021 Oct 8;11(1):20075. doi: 10.1038/s41598-021-99562-9. Sci Rep. 2021. PMID: 34625606 Free PMC article.
-
Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.Mol Neurobiol. 2019 Sep;56(9):6156-6167. doi: 10.1007/s12035-019-1500-y. Epub 2019 Feb 8. Mol Neurobiol. 2019. PMID: 30734227 Free PMC article.
-
Deficient Wnt Signaling and Synaptic Vulnerability in Alzheimer's Disease: Emerging Roles for the LRP6 Receptor.Front Synaptic Neurosci. 2018 Oct 30;10:38. doi: 10.3389/fnsyn.2018.00038. eCollection 2018. Front Synaptic Neurosci. 2018. PMID: 30425633 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources